News - 19 May 2009
MDRNA, Inc. (NASDAQ: MRNA),
a biotechnology company focused on the development and commercialization of
therapeutic products based on RNA interference (RNAi), announced today positive
creates automated products for research and development chemists and is a world
leader in flow chemistry, microreactor and automation technology.
products are used in a...
The Möbius® makes reliable, reproducible, and non-destructive electrophoretic mobility and zeta potential measurements of macromolecules smaller than 2 nm in radius, as well as micron-size...
Moisture analyzer MAX is equipped with backlit graphic display, which makes the instrument's interface transparent and easy to use. User menu includes data base with 99 drying procedures, with...
Article - 17 May 2013
In the past decades genomics has been developed and segregated into high throughput applications like blood and food diagnostics, very complex assays (e.g. epigenetics analysis) and highly reliable...
News - 2 Jun 2015
Dicerna Pharmaceuticals, Inc., a leader in the development of RNAi therapeutics, today presented preliminary safety and efficacy data from an ongoing Phase 1 study of DCR-MYC in patients with advanced...
News - 22 Apr 2014
Rexahn Pharmaceuticals, Inc. a clinical stage biopharmaceutical company developing best-in-class therapeutics for the treatment of cancer, today announced promising preclinical results for...
News - 3 Apr 2014
Tekmira Pharmaceuticals Corporation, a leading developer of RNA interference (RNAi) therapeutics, announced that recent advances in its anti-viral product platform were presented at the 6th...
News - 11 Apr 2013
BIND Therapeutics, a clinical-stage biopharmaceutical company developing a new class of highly selective targeted and programmable therapeutics called Accurins™, announced today that positive...
News - 18 Aug 2010
The concentrations of toxic nitrogen oxide that are present in German cities regularly exceed the maximum permitted levels. That’s now about to change, as innovative paving slabs that will help...